Search - tctmd.com

Displaying 241 - 260 of 1554

Sort: Relevancy | Date

Presentation TCT 2024

Transcatheter Aortic Valve Replacement in Patients With Systolic Heart Failure and Moderate Aortic Stenosis: The TAVR UNLOAD Trial

Presenter: Nicolas Van Mieghem

October 28, 2024

Presentation TCT 2024

TCT 616: Wire-Assisted Percutanoeus Mitral Commisuratomy Is Significantly Faster Than the Tradidtional Inoue Balloon Technique: A Randomized Clinical Trial

Presenter: Chala Oljira

October 28, 2024

Presentation TCT 2024

Transcatheter Aortic Valve Replacement for Asymptomatic Severe Aortic Stenosis: Results of the EARLY TAVR Trial

Presenter: Philippe Genereux

October 28, 2024

Presentation TCT 2024

A Sensible Approach to CEP for TAVR: From Clinical Trials to Clinical Practices

Presenter: Aakriti Gupta

October 28, 2024

Presentation TCT 2024

TCT 974: Characteristics and Outcomes of Patients Screened out of Tricuspid Transcatheter Edge-to-Edge Repair or Transcatheter Tricuspid Valve Replacement Clinical Trials

Presenter: Tai Pham

October 28, 2024

Presentation TCT 2024

1-Year and Landmark 6-12 Month Clinical Outcomes Among Patients in Complex Lesion Subsets Treated With DynamX Bioadaptor Compared to a Contemporary Drug Eluting Stent From the INFINITY-SWEDEHEART

Presenter: David Erlinge

October 28, 2024

Presentation TCT 2024

TCT 1010: Enhanced Clinical Benefit of Preventive PCI of Vulnerable Coronary Plaques in Patients With Concomitant Non-Target Vessel PCI: A Prespecified Subgroup Analysis of the PREVENT Trial

Presenter: Soo Yeon An

October 28, 2024

Presentation TCT 2024

TCT 1006: Impact of Angiographic Diameter Stenosis on the Clinical Benefit of Preventive PCI of Vulnerable Plaque: A Post-hoc Analysis of the PREVENT Trial

Presenter: Do-Yoon Kang

October 28, 2024

Presentation TCT 2024

TCT 492: One-Year Clinical Outcomes After PCI With AGENT Paclitaxel-Coated Balloon Among Underrepresented Racial and Ethnic Subgroups With In-Stent Restenosis: Analysis of the AGENT IDE Trial

Presenter: NULL

October 28, 2024

Presentation TCT 2024

Transcatheter Valve Selection for Redo TAVR and Overview of Clinical Trials

Presenter: Radoslaw Parma

October 28, 2024

Presentation TCT 2024

Clinical Trials in the Post ATTRACT Era: What is the New State of the Art Data and Upcoming Trials Guiding DVT Intervention?

Presenter: Suresh Vedantham

October 28, 2024

Presentation TCT 2024

Interatrial Shunts (IASD): From Theory to Clinical Trials

Presenter: Javed Butler

October 28, 2024

Presentation TCT 2024

Experience With J-Valve – Technology, Case Examples, and Clinical Trials

Presenter: Santiago Garcia

October 28, 2024

Presentation TCT 2024

Experience With JenaValve – Technology, Case Examples, and Clinical Trials

Presenter: Raj Makkar

October 28, 2024

Presentation TCT 2024

TCT 486: Ultrasound Based Renal Denervation Reduces Blood Pressure in Patients With Chronic Kidney Disease: Results of a Multicenter Prospective Randomized Sham-Controlled Blinded Investigator Initiated Trial

Presenter: Roland Schmieder

October 28, 2024

Presentation TCT 2024

TCT 481: Renal Artery Imaging Through Long-Term Follow-Up Following Radiofrequency Renal Denervation: Results From the SPYRAL Clinical Trial Program

Presenter: Felix Mahfoud

October 28, 2024

Presentation TCT 2024

TCT 416: Impact of Total Stent Length on Long-Term Clinical Outcomes With Newer-Generation Drug-Eluting Stents in ST-Segment Elevation Myocardial Infarction: A Subgroup Analysis From the Biostemi ES Randomized Trial

Presenter: Juan F. Iglesias

October 28, 2024

Presentation TCT 2024

Long-term Safety and Efficacy of Radiofrequency Renal Denervation in the Presence of Antihypertensive Drugs: 24-Month Results From the SPYRAL HTN-ON MED Randomized Trial

Presenter: David Kandzari

October 28, 2024

Presentation TCT 2024

Comparison of Noncompliant Balloon With Drug-Coating Balloon Angioplasties for Side Branch After Provisional Stenting for Patients With True Coronary BIFurcation Lesions: The Prospective, Multicenter, Randomized DCB-BIF Trial

Presenter: Shao-Liang Chen

October 28, 2024

Presentation TCT 2024

Early Administration of Heparin at First Medical Contact Versus in the Cathlab for STEMI Patients Undergoing Primary Percutaneous Coronary Intervention (HELP-PCI): A Multicenter, Randomized Trial

Presenter: Jing Chen

October 28, 2024

Advertisement

Transcatheter Aortic Valve Replacement in Patients With Systolic Heart Failure and Moderate Aortic Stenosis: The TAVR UNLOAD Trial

TCT 616: Wire-Assisted Percutanoeus Mitral Commisuratomy Is Significantly Faster Than the Tradidtional Inoue Balloon Technique: A Randomized Clinical Trial

Transcatheter Aortic Valve Replacement for Asymptomatic Severe Aortic Stenosis: Results of the EARLY TAVR Trial

A Sensible Approach to CEP for TAVR: From Clinical Trials to Clinical Practices

TCT 974: Characteristics and Outcomes of Patients Screened out of Tricuspid Transcatheter Edge-to-Edge Repair or Transcatheter Tricuspid Valve Replacement Clinical Trials

1-Year and Landmark 6-12 Month Clinical Outcomes Among Patients in Complex Lesion Subsets Treated With DynamX Bioadaptor Compared to a Contemporary Drug Eluting Stent From the INFINITY-SWEDEHEART

TCT 1010: Enhanced Clinical Benefit of Preventive PCI of Vulnerable Coronary Plaques in Patients With Concomitant Non-Target Vessel PCI: A Prespecified Subgroup Analysis of the PREVENT Trial

TCT 1006: Impact of Angiographic Diameter Stenosis on the Clinical Benefit of Preventive PCI of Vulnerable Plaque: A Post-hoc Analysis of the PREVENT Trial

TCT 492: One-Year Clinical Outcomes After PCI With AGENT Paclitaxel-Coated Balloon Among Underrepresented Racial and Ethnic Subgroups With In-Stent Restenosis: Analysis of the AGENT IDE Trial

Transcatheter Valve Selection for Redo TAVR and Overview of Clinical Trials

Clinical Trials in the Post ATTRACT Era: What is the New State of the Art Data and Upcoming Trials Guiding DVT Intervention?

Interatrial Shunts (IASD): From Theory to Clinical Trials

Experience With J-Valve – Technology, Case Examples, and Clinical Trials

Experience With JenaValve – Technology, Case Examples, and Clinical Trials

TCT 486: Ultrasound Based Renal Denervation Reduces Blood Pressure in Patients With Chronic Kidney Disease: Results of a Multicenter Prospective Randomized Sham-Controlled Blinded Investigator Initiated Trial

TCT 481: Renal Artery Imaging Through Long-Term Follow-Up Following Radiofrequency Renal Denervation: Results From the SPYRAL Clinical Trial Program

TCT 416: Impact of Total Stent Length on Long-Term Clinical Outcomes With Newer-Generation Drug-Eluting Stents in ST-Segment Elevation Myocardial Infarction: A Subgroup Analysis From the Biostemi ES Randomized Trial

Long-term Safety and Efficacy of Radiofrequency Renal Denervation in the Presence of Antihypertensive Drugs: 24-Month Results From the SPYRAL HTN-ON MED Randomized Trial

Comparison of Noncompliant Balloon With Drug-Coating Balloon Angioplasties for Side Branch After Provisional Stenting for Patients With True Coronary BIFurcation Lesions: The Prospective, Multicenter, Randomized DCB-BIF Trial

Early Administration of Heparin at First Medical Contact Versus in the Cathlab for STEMI Patients Undergoing Primary Percutaneous Coronary Intervention (HELP-PCI): A Multicenter, Randomized Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content